VaxGen to acquire diaDexus - MarketLine Financial Deals

VaxGen to acquire diaDexus

VaxGen to acquire diaDexus - MarketLine Financial Deals
VaxGen to acquire diaDexus
Published Apr 14, 2010
4 pages — Published Apr 14, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report


VaxGen, Inc. has entered into a non-binding summary of terms with diaDexus, Inc. pursuant to which VaxGen would acquire all of the outstanding shares of diaDexus, a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products.

Document ID
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author

Cite this Report

MarketLine Financial Deals. "VaxGen to acquire diaDexus" Apr 14, 2010. Alacra Store. May 22, 2018. <>
MarketLine Financial Deals. (2010). VaxGen to acquire diaDexus Apr 14, 2010. New York, NY: Alacra Store. Retrieved May 22, 2018 from <>
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.